Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines
Errataetall: | |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
---|---|
Enthalten in: |
The Journal of infection - 88(2024), 3 vom: 01. März, Seite 106119 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kalkeri, Raj [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.03.2024 Date Revised 19.03.2024 published: Print-Electronic UpdateOf: medRxiv. 2024 Jan 18;:. - PMID 38293205 Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2024.106119 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368504433 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368504433 | ||
003 | DE-627 | ||
005 | 20240319232656.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240216s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2024.106119 |2 doi | |
028 | 5 | 2 | |a pubmed24n1336.xml |
035 | |a (DE-627)NLM368504433 | ||
035 | |a (NLM)38360356 | ||
035 | |a (PII)S0163-4453(24)00053-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kalkeri, Raj |e verfasserin |4 aut | |
245 | 1 | 0 | |a Altered IgG4 antibody response to repeated mRNA versus recombinant protein SARS-CoV-2 vaccines |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.03.2024 | ||
500 | |a Date Revised 19.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a UpdateOf: medRxiv. 2024 Jan 18;:. - PMID 38293205 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Letter | |
650 | 7 | |a COVID-19 Vaccines |2 NLM | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
700 | 1 | |a Zhu, Mingzhu |e verfasserin |4 aut | |
700 | 1 | |a Cloney-Clark, Shane |e verfasserin |4 aut | |
700 | 1 | |a Plested, Joyce S |e verfasserin |4 aut | |
700 | 1 | |a Parekh, Anand |e verfasserin |4 aut | |
700 | 1 | |a Gorinson, Drew |e verfasserin |4 aut | |
700 | 1 | |a Cai, Rongman |e verfasserin |4 aut | |
700 | 1 | |a Mahato, Soham |e verfasserin |4 aut | |
700 | 1 | |a Ramanathan, Pradhipa |e verfasserin |4 aut | |
700 | 1 | |a Aurelia, Lidwina Carissa |e verfasserin |4 aut | |
700 | 1 | |a Selva, Kevin John |e verfasserin |4 aut | |
700 | 1 | |a Marchese, Anthony M |e verfasserin |4 aut | |
700 | 1 | |a Fries, Louis |e verfasserin |4 aut | |
700 | 1 | |a Chung, Amy W |e verfasserin |4 aut | |
700 | 1 | |a Dunkle, Lisa M |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 88(2024), 3 vom: 01. März, Seite 106119 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:88 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:106119 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2024.106119 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 88 |j 2024 |e 3 |b 01 |c 03 |h 106119 |